Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seok-Goo Cho

Showing results (21-30 of 275) with videos related to

Pageof 28
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|August 28, 2020
Differentiation of soft-tissue lymphoma from undifferentiated sarcoma: apparent diffusion coefficient histogram analysisJi Hyun Hong, Won-Hee Jee, Sunyoung Whang, et al.
Plos One|November 23, 2021
Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatmentRae-Young Kim, Jae Hyun Park, Mirinae Kim, et al.
Transplantation and Cellular Therapy|January 11, 2026
Cytokine-induced Killer Cell Therapy as a Post-remission Strategy in High-risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical StudyGi-June Min, Nayoun Kim, Keon-Il Im, et al.
The Korean Journal of Internal Medicine|October 21, 2017
Third-party regulatory T cells prevent murine acute graft-versus-host diseaseJung-Yeon Lim, Keon-Il Im, Yunejin Song, et al.
American Journal of Translational Research|April 12, 2019
Down-regulation of intracellular reactive oxygen species attenuates P-glycoprotein-associated chemoresistance in Epstein-Barr virus-positive NK/T-cell lymphomaYoung-Sun Nam, Keon-Il Im, Nayoun Kim, et al.
Medicine|September 30, 2016
FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcomeEun Ji Han, Joo Hyun O, Hyukjin Yoon, et al.
Frontiers in Immunology|January 10, 2022
Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 TreatmentNayoun Kim, Jong-Min Lee, Eun-Jee Oh, et al.
Cytotherapy|February 14, 2026
Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphomaTong-Yoon Kim, Kyoung Il Min, Gi-June Min, et al.
Stem Cells and Development|September 29, 2015
IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the TumorNayoun Kim, Young-Sun Nam, Keon-Il Im, et al.
Cytokine|December 2, 2015
Therapeutic potential of low-dose IL-2 in a chronic GVHD patient by in vivo expansion of regulatory T cellsNayoun Kim, Young-Woo Jeon, Young-Sun Nam, et al.
Pageof 28

Showing results (21-30 of 275) with videos related to

Sort By:
Pageof 28
Acta Radiologica (Stockholm, Sweden : 1987)|August 28, 2020
Differentiation of soft-tissue lymphoma from undifferentiated sarcoma: apparent diffusion coefficient histogram analysisJi Hyun Hong, Won-Hee Jee, Sunyoung Whang, et al.
Plos One|November 23, 2021
Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatmentRae-Young Kim, Jae Hyun Park, Mirinae Kim, et al.
Transplantation and Cellular Therapy|January 11, 2026
Cytokine-induced Killer Cell Therapy as a Post-remission Strategy in High-risk Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Prospective Investigator-Initiated Clinical StudyGi-June Min, Nayoun Kim, Keon-Il Im, et al.
The Korean Journal of Internal Medicine|October 21, 2017
Third-party regulatory T cells prevent murine acute graft-versus-host diseaseJung-Yeon Lim, Keon-Il Im, Yunejin Song, et al.
American Journal of Translational Research|April 12, 2019
Down-regulation of intracellular reactive oxygen species attenuates P-glycoprotein-associated chemoresistance in Epstein-Barr virus-positive NK/T-cell lymphomaYoung-Sun Nam, Keon-Il Im, Nayoun Kim, et al.
Medicine|September 30, 2016
FDG PET/CT response in diffuse large B-cell lymphoma: Reader variability and association with clinical outcomeEun Ji Han, Joo Hyun O, Hyukjin Yoon, et al.
Frontiers in Immunology|January 10, 2022
Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 TreatmentNayoun Kim, Jong-Min Lee, Eun-Jee Oh, et al.
Cytotherapy|February 14, 2026
Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed or refractory large B-cell lymphomaTong-Yoon Kim, Kyoung Il Min, Gi-June Min, et al.
Stem Cells and Development|September 29, 2015
IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the TumorNayoun Kim, Young-Sun Nam, Keon-Il Im, et al.
Cytokine|December 2, 2015
Therapeutic potential of low-dose IL-2 in a chronic GVHD patient by in vivo expansion of regulatory T cellsNayoun Kim, Young-Woo Jeon, Young-Sun Nam, et al.
Pageof 28